Connor, Clark & Lunn Investment Management Ltd. Wave Life Sciences Ltd. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $20 Billion
- Q4 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 387,871 shares of WVE stock, worth $4.1 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
387,871
Previous 325,009
19.34%
Holding current value
$4.1 Million
Previous $2.67 Million
80.0%
% of portfolio
0.02%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding WVE
# of Institutions
192Shares Held
122MCall Options Held
430KPut Options Held
330K-
Ra Capital Management, L.P. Boston, MA18.2MShares$192 Million3.65% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.62MShares$102 Million0.22% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.26MShares$87.3 Million1.98% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$71.2 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.71MShares$71 Million0.81% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $918M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...